Ovarian cancer gene hunt launches in italy

NCT ID NCT07169396

Recruiting now Knowledge-focused Sponsor: Azienda USL Reggio Emilia - IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study looks at genetic targets in ovarian cancer, focusing on a common type called high-grade serous carcinoma. Researchers will analyze tumor tissue from 180 adult women to understand which genes are involved. The goal is to find new ways to diagnose or treat the disease, but this is an observational study, not a treatment trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could point toward new diagnostic markers or treatment targets for ovarian cancer.
What could go wrong: This is an early-stage observational study, not a treatment trial. It may not directly lead to new therapies, and findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ovarian cancer ovarian carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVARIAN CANCER

Contacts and locations

Locations

Azienda USL IRCCS di Reggio Emilia
RECRUITING

Reggio Emilia, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.